These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19464994)

  • 1. Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasma.
    Damen CW; de Groot ER; Heij M; Boss DS; Schellens JH; Rosing H; Beijnen JH; Aarden LA
    Anal Biochem; 2009 Aug; 391(2):114-20. PubMed ID: 19464994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioanalysis of trastuzumab in human serum using precipitate-enhanced ellipsometry.
    Damen CW; Speijer H; Hermens WT; Schellens JH; Rosing H; Beijnen JH
    Anal Biochem; 2009 Oct; 393(1):73-9. PubMed ID: 19523916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum.
    Damen CW; Derissen EJ; Schellens JH; Rosing H; Beijnen JH
    J Pharm Biomed Anal; 2009 Dec; 50(5):861-6. PubMed ID: 19487098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma.
    Jamieson D; Cresti N; Verrill MW; Boddy AV
    J Immunol Methods; 2009 Jun; 345(1-2):106-11. PubMed ID: 19376123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of ELISA for herceptin detection in human serum.
    Maple L; Lathrop R; Bozich S; Harman W; Tacey R; Kelley M; Danilkovitch-Miagkova A
    J Immunol Methods; 2004 Dec; 295(1-2):169-82. PubMed ID: 15627622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trastuzumab quantification in serum: a new, rapid, robust ELISA assay based on a mimetic peptide that specifically recognizes trastuzumab.
    Cardinali B; Lunardi G; Millo E; Armirotti A; Damonte G; Profumo A; Gori S; Iacono G; Levaggi A; Del Mastro L
    Anal Bioanal Chem; 2014 Jul; 406(18):4557-61. PubMed ID: 24828979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
    Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
    J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a peptide ELISA for the detection of rituximab in serum.
    Blasco H; Lalmanach G; Godat E; Maurel MC; Canepa S; Belghazi M; Paintaud G; Degenne D; Chatelut E; Cartron G; Le Guellec C
    J Immunol Methods; 2007 Aug; 325(1-2):127-39. PubMed ID: 17651747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer.
    Lennon S; Barton C; Banken L; Gianni L; Marty M; Baselga J; Leyland-Jones B
    J Clin Oncol; 2009 Apr; 27(10):1685-93. PubMed ID: 19255335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel enzyme-linked immunosorbent assay for determination of fluvastatin in plasma at picogram level.
    Darwish IA; Al-Obaid AR; Al-Malaq HA
    Talanta; 2009 Nov; 80(1):179-83. PubMed ID: 19782210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
    Witzel I; Loibl S; von Minckwitz G; Mundhenke C; Huober J; Hanusch C; Henschen S; Hauschild M; Lantzsch T; Tesch H; Latos K; Just M; Hilfrich J; Barinoff J; Eulenburg CZ; Roller M; Untch M; Müller V
    Breast Cancer Res Treat; 2010 Sep; 123(2):437-45. PubMed ID: 20623180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.
    Stemmler HJ; Schmitt M; Willems A; Bernhard H; Harbeck N; Heinemann V
    Anticancer Drugs; 2007 Jan; 18(1):23-8. PubMed ID: 17159499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.
    Goldenberg MM
    Clin Ther; 1999 Feb; 21(2):309-18. PubMed ID: 10211534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab.
    Strohner P; Korn S; Buhl R; Becher G
    J Immunoassay Immunochem; 2013; 34(1):83-93. PubMed ID: 23323984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of anti-idiotype antibodies to human monoclonal antibody].
    Harada R; Takahashi N; Owaki I; Kannagi R; Endo N; Morita N; Inoue M
    Igaku Kenkyu; 1992 Feb; 62(1):1-18. PubMed ID: 1523940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
    Baselga J; Tripathy D; Mendelsohn J; Baughman S; Benz CC; Dantis L; Sklarin NT; Seidman AD; Hudis CA; Moore J; Rosen PP; Twaddell T; Henderson IC; Norton L
    Semin Oncol; 1999 Aug; 26(4 Suppl 12):78-83. PubMed ID: 10482197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.